Register entry
- Registered sites
- 0
- Active NDC listings
- 39
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
3939 active NDC listings: 39 bulk ingredient. By marketing category: BULK INGREDIENT 27, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 12.
| Dosage form | NDCs |
|---|---|
| powder | 39 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| curia new york, inc. | 37 |
| curia new york, inc | 2 |
Catalogue
Marketed products
39| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Alogliptin | powder | 65392-2813BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Ambenonium Chloride | powder | 65392-1002BULK INGREDIENT |
| - | Amphetamine Aspratate Monohydrate | powder | 65392-0117BULK INGREDIENT |
| - | Amphetamine Sulfate | powder | 65392-0110BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Belinostat | powder | 65392-2509BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Cantharidin | powder | 65392-3416BULK INGREDIENT |
| - | Cetalkonium Chloride | powder | 65392-1201BULK INGREDIENT |
| - | Dextroamphetamine Saccharate | powder | 65392-0115BULK INGREDIENT |
| - | Dextroamphetamine Sulfate | powder | 65392-0114BULK INGREDIENT |
| - | Diatrizoate Meglumine | powder | 65392-1314BULK INGREDIENT |
| - | Diatrizoate Sodium | powder | 65392-1701BULK INGREDIENT |
| - | Echothiophate Iodide | powder | 65392-1402BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Enzalutamide | powder | 65392-2209BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Epinephrine | powder | 65392-1405BULK INGREDIENT |
| - | Gamma Hydroxybutyric Acid | powder | 65392-3417BULK INGREDIENT |
| - | Lifitegrast | powder | 65392-2803BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Lisdexamfetamine Dimesylate | powder | 65392-0118BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | MGL-3196 | powder | 65392-3203BULK INGREDIENT |
| - | Mafenide Acetate | powder | 65392-2801BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Mangafodipir Trisodium | powder | 65392-2204BULK INGREDIENT |
| - | Meperidine Hydrochloride | powder | 65392-0923BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Metolazone | powder | 65392-2201BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Milrinone | powder | 65392-2202BULK INGREDIENT |
| - | Norepinephrine Bitartrate | powder | 65392-2301BULK INGREDIENT |
| - | Pentobarbital Sodium | powder | 65392-0227BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Pralatrexate | powder | 65392-2510BULK INGREDIENT |
| - | Pralidoxime Chloride | powder | 65392-2503BULK INGREDIENT |
| - | Primaquine Phosphate | powder | 65392-2502BULK INGREDIENT |
| - | Racepinephrine Hydrochloride | powder | 65392-2701BULK INGREDIENT |
| - | SNDX-5613 | powder | 65392-3402BULK INGREDIENT |
| - | SNDX-5613 | powder | 65392-3415BULK INGREDIENT |
| - | Sodium Thiosulfate Pentahydrate | powder | 65392-3403BULK INGREDIENT |
| - | Tedizolid Phosphate | powder | 65392-2912BULK INGREDIENT |
| - | Trientine Hydrochloride | powder | 65392-2901BULK INGREDIENT |
| - | Vorinostat Coarse | powder | 65392-3101BULK INGREDIENT |
| - | Vorinostat Fine | powder | 65392-3102BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | brigatinib | powder | 65392-3311BULK INGREDIENT |
| - | dexmethylphenidate hydrochloride | powder | 65392-3418BULK INGREDIENT |
| - | palovarotene | powder | 65392-3414BULK INGREDIENT |
Enquiry
Common questions
- Is Curia New York, Inc. FDA approved?
- Curia New York, Inc. holds no registered establishment of its own; 39 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Curia New York, Inc. make?
- 39 products are listed under Curia New York, Inc. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.